A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) was first identified in 2012, and it continues to threaten human health worldwide. No MERS vaccines are licensed for human use, reinforcing the urgency to develop safe and efficacious vaccines to prevent MERS. MERS-CoV spike protein form...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Virology
Autors principals: Tai, Wanbo, Zhao, Guangyu, Sun, Shihun, Guo, Yan, Wang, Yufei, Tao, Xinrong, Tseng, Chien-Te K., Li, Fang, Jiang, Shibo, Du, Lanying, Zhou, Yusen
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5167628/
https://ncbi.nlm.nih.gov/pubmed/27750111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2016.10.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars